Results 171 to 180 of about 58,791 (313)
Dramatic Regression of Chronic Lymphocytic Leukemia in the First Patient Treated With Donor-Derived Genetically-Engineered Anti-CD19-Chimeric-Antigen-Receptor-Expressing T Cells After Allogeneic Hematopoietic Stem Cell Transplantation
, 2011 James N. Kochenderfer, Mark E. Dudley, I. Maric, Steven A. Feldman, Rachel B. Salit, Nancy M. Hardy, Paula Layton, Bazetta Blacklock-Schuver, Jennifer Wilder, Laura Devillier, Ronald E. Gress, Robert Morgan, Steven A. Rosenberg, Michael Bishop +13 moreopenalex +1 more sourceAllogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignancies. [PDF]
Blood AdvLoschi M, Villy MC, Galimard JE, Auboiroux MM, Gachard N, Perani A, Duchmann M, Largeaud L, Nguyen S, Sicre de Fontbrune F, Robin M, Yakoub-Agha I, Daguindau E, Chantepie S, Charbonnier A, Lebon D, Maury S, Labussiere-Wallet H, Huynh A, Forcade E, Castilla-Llorente C, Cluzeau T, Adès L, D'aveni M, Devillier R, Maillard N, Benachour S, Dombret H, Récher C, Pigneux A, Clappier E, Delabesse E, Duployez N, Turlure P, Peffault de Latour R, Sébert M. +35 moreeuropepmc +1 more sourceVenetoclax combined with cladribine, idarubicin, cytarabine (CLIA‐VEN) results in higher remission rates over conventional 7 + 3 chemotherapy without increased toxicity in newly diagnosed acute myeloid leukaemia
British Journal of Haematology, EarlyView.Summary
Induction chemotherapy in fit de novo acute myeloid leukaemia (AML) patients has historically combined an anthracycline with standard‐dose cytarabine (‘7 + 3’) despite complete response (CR) rates of 50%–70%. In May 2023, our institution adopted the utilization of cladribine, cytarabine, idarubicin and venetoclax (CLIA‐VEN) for intensive ...Benjamin J. Lee, Shawn P. Griffin, Jean Doh, Anthony Quach, Yujiao Sun, Piyatida Chumnumsiriwath, Stefan O. Ciurea, Jorge Ramos‐Perez, Polina Bellman, Deepa Jeyakumar, Piyanuch Kongtim, Kiran Naqvi +11 morewiley +1 more sourceExperience with second allogeneic hematopoietic stem cell transplantation in Chilean patients: A single-center study. [PDF]
Hematol Transfus Cell TherFlores Y, Díaz J, Rojas P, Salinas J, Gutiérrez C, Vidal M, Jara V, Rivera E, García MJ, Sandoval V, Palacios F, Vergara M, Ocqueteau M, Sarmiento M. +13 moreeuropepmc +1 more sourceSafety and Persistence of Infused CD19-Car-Modified Multivirus Specific CTLs in B Cell Malignancies Post Allogeneic Hematopoietic Stem Cell Transplantation
, 2012 Carolina Colli Cruz, Kenneth Micklethwaite, Barbara Savoldo, Stephanie Ku, RA Krance, Oumar Diouf, Ravindra R. Kamble, Alana A. Kennedy‐Nasser, A. John Barrett, Elizabeth J. Shpall, HE Heslop, Cliona M. Rooney, M.K. Brenner, C.M. Bollard, Gianpietro Dotti +14 moreopenalex +1 more sourceProphylactic donor lymphocyte infusions after first allogeneic hematopoietic stem cell transplantation in children with acute leukemia. [PDF]
Blood ResWei A, Jia C, Zhu G, Yang J, Zheng J, Jing Y, Zhang M, Cai L, Han Y, Sun X, Shu C, Chen W, Qin M, Wang B, Luo Y. +14 moreeuropepmc +1 more source
